Trends in underlying causes of death in solid organ transplant recipients between 2010 and 2020: Using the CLASS method for determining specific causes of death

Monitoring specific underlying causes of death in solid organ transplant (SOT) recipients is important in order to identify emerging trends and health challenges. This retrospective cohort study includes all SOT recipients transplanted at Rigshospitalet between January 1st, 2010 and December 31st, 2019. The underlying cause of death was determined using the newly developed Classification of Death Causes after Transplantation (CLASS) method. Cox regression analyses assessed risk factors for all-cause and cause-specific mortality. Of the 1774 SOT recipients included, 299 patients died during a total of 7511 person-years of follow-up (PYFU) with cancer (N=57, 19%), graft rejection (N=55, 18%) and infections (N=52, 17%) being the most frequent causes of death. We observed a lower risk of all-cause death with increasing transplant year (HR 0.91, 95% CI 0.86-0.96 per 1-year increase), alongside death from graft rejection (HR 0.84 per year, 95% CI 0.74-0.95) and death from infections (HR 0.87 per year, 95% CI 0.77-0.98). Further, there was a trend towards lower cumulative incidence of death from cardiovascular disease, graft failure and cancer in more recent years, while death from other organ specific and non-organ specific causes did not decrease. All-cause mortality among SOT recipients has decreased over the past decade, mainly due to a decrease in graft rejection- and infection-related deaths. Conversely, causes from a broad range of diseases have remained unchanged, suggesting that cause of death among SOT recipients is increasingly diverse and warrants a multidisciplinary effort and attention in the future.

[1]  S. Chadban,et al.  Death after Kidney Transplantation: An Analysis by Era and Time Post-Transplant. , 2020, Journal of the American Society of Nephrology : JASN.

[2]  L. Punnoose,et al.  Outcomes of Older Patients in the Recent Era of Heart Kidney Transplantation. , 2020, Transplantation proceedings.

[3]  J. Lundgren,et al.  Evaluation of an electronic, patient‐focused management system aimed at preventing cytomegalovirus disease following solid organ transplantation , 2020, Transplant infectious disease : an official journal of the Transplantation Society.

[4]  B. Meiser,et al.  The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[5]  L. Magder,et al.  Cancer‐attributable mortality among solid organ transplant recipients in the United States: 1987 through 2014 , 2019, Cancer.

[6]  F. Durand,et al.  Age and liver transplantation. , 2019, Journal of hepatology.

[7]  Hao Liu,et al.  No Gains in Long-term Survival After Liver Transplantation Over the Past Three Decades , 2019, Annals of surgery.

[8]  K. Zieniewicz,et al.  2018 Annual Report of the European Liver Transplant Registry (ELTR) – 50‐year evolution of liver transplantation , 2018, Transplant international : official journal of the European Society for Organ Transplantation.

[9]  W. Winkelmayer,et al.  Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996–2014) , 2018, American Journal of Nephrology.

[10]  S. Acuna Etiology of increased cancer incidence after solid organ transplantation. , 2018, Transplantation reviews.

[11]  P. Finne,et al.  Secular Trends in Infection-Related Mortality after Kidney Transplantation. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[12]  D. Davenport,et al.  Outcome of kidney transplant in primary, repeat, and kidney‐after‐nonrenal solid‐organ transplantation: 15‐year analysis of recent UNOS database , 2017, Clinical transplantation.

[13]  A. Mocroft,et al.  Classification of death causes after transplantation (CLASS) , 2017, Medicine.

[14]  J. Sonett,et al.  Long-term outcomes and management of lung transplant recipients. , 2017, Best practice & research. Clinical anaesthesiology.

[15]  R. Sutradhar,et al.  Cancer Mortality Among Recipients of Solid-Organ Transplantation in Ontario, Canada. , 2016, JAMA Oncology.

[16]  L. Lund,et al.  The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report--2015; Focus Theme: Early Graft Failure. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  C. Ahn,et al.  Pretransplant malnutrition, inflammation, and atherosclerosis affect cardiovascular outcomes after kidney transplantation , 2015, BMC Nephrology.

[18]  Henrik Toft Sørensen,et al.  The Danish Civil Registration System as a tool in epidemiology , 2014, European Journal of Epidemiology.

[19]  A. Keogh,et al.  De novo Cancer‐Related Death in Australian Liver and Cardiothoracic Transplant Recipients , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  C. Kotton CMV: Prevention, Diagnosis and Therapy , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  A. Burroughs,et al.  Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  S. Kennedy,et al.  Association of the malnutrition-inflammation score with clinical outcomes in kidney transplant recipients. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  S. Vowler,et al.  The Pattern of Late Mortality in Liver Transplant Recipients in the United Kingdom , 2011, Transplantation.

[24]  A. Crispin,et al.  The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. , 2007, Kidney international.

[25]  J. Neuberger,et al.  Life expectancy of adult liver allograft recipients in the UK , 2006, Gut.

[26]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Circulation.

[27]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.

[28]  J. Hill,et al.  Evolving trends in risk profiles and causes of death after heart transplantation: a ten-year multi-institutional study. , 2003, The Journal of thoracic and cardiovascular surgery.

[29]  A. Kakita,et al.  Cause of Death in Renal Transplant Patients: A Comparison Between Azathioprine and Ciclosporin , 2001, Surgery Today.

[30]  J. Briggs Causes of death after renal transplantation. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  J. Salaman Death after kidney transplantation. , 1974, British medical journal.

[32]  K. McCurry Brief Overview of Lung, Heart, and Heart-Lung Transplantation. , 2019, Critical care clinics.

[33]  L. Lund,et al.  The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.